نتایج جستجو برای: hbsag mutations

تعداد نتایج: 177547  

2012
Edouard Tuaillon Anne-Marie Mondain Nicolas Nagot Laure Ottomani Dramane Kania Erika Nogue Pierre-Alain Rubbo Georges-Philippe Pageaux Philippe Van de Perre Jacques Ducos

BACKGROUND The decline in hepatitis B virus surface antigen (HBsAg) may be an early predictor of the viral efficacy of Hepatitis B virus (HBV) therapy. The HBsAg levels obtained by different immunoassays now need comparing and the relationships between levels of HBsAg and HBV DNA alongside HBsAg and genotype must be evaluated. METHODOLOGY/PRINCIPAL FINDINGS HBsAg levels were compared among 80...

2013
Sofiane Mohamed Audrey Raimondo Guillaume Pénaranda Claire Camus Denis Ouzan Sophie Ravet Marc Bourlière Hacène Khiri Patrick Dukan Daniel Olive Philippe Halfon

BACKGROUND AIMS Dried blood spots (DBS) on filter paper have been successfully used to diagnose and monitor several infectious diseases. The aim was to investigate the performance of DBS in hepatitis B virus (HBV) diagnosis using commercial tests in comparison to standard methods. METHODS Paired DBS and plasma samples were collected from 200 patients: 100 patients with HBsAg negative status a...

Journal: :The Journal of infectious diseases 2009
Ming-Lung Yu Chuan-Mo Lee Wan-Long Chuang Sheng-Nan Lu Chia-Yen Dai Jee-Fu Huang Zu-Yau Lin Tsung-Hui Hu Chien-Hung Chen Chao-Hung Hung Jin-Houng Wang Chi-Ling Chen Jia-Horng Kao Ming-Yang Lai Chen-Hua Liu Tung-Hung Su Shun-Sheng Wu Li-Ying Liao Hsing-Tao Kuo You-Chen Chao Shui-Yi Tung Sien-Sing Yang Pei-Jer Chen Chun-Jen Liu Ding-Shinn Chen

BACKGROUND With use of peginterferon alfa-2a and ribavirin combination therapy in patients with dual chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, 11.2% of patients achieved clearance of hepatitis B surface antigen (HBsAg) at 6 months after treatment; however, reactivation of HBV DNA was observed in 36.3%. We investigated the predictive potential of HBsAg quantification...

Journal: :Journal of virology 1995
R Schirmbeck W Böhm K Ando F V Chisari J Reimann

The efficiency of different vaccination techniques to prime in vivo major histocompatibility complex class I-restricted murine cytotoxic T-lymphocyte (CTL) precursors to hepatitis B virus small surface antigen (HBsAg) was investigated. Mice were immunized either by injection of a low dose of recombinant HBsAg protein preparations (native HBsAg particles or denatured HBsAg monomers) without adju...

2012
Linda Dunford Michael J. Carr Jonathan Dean Linh Thuy Nguyen Thu Hong Ta Thi Binh Thanh Nguyen Jeff Connell Suzie Coughlan Hien Tran Nguyen William W. Hall Lan Anh Nguyen Thi

Hepatitis B (HBV) infection is endemic in Viet Nam, with up to 8.4 million individuals estimated to be chronically infected. We describe results of a large, multicentre seroepidemiological and molecular study of the prevalence of HBV infection and blood-borne viral coinfections in Viet Nam. Individuals with varying risk factors for infection (n = 8654) were recruited from five centres; Ha Noi, ...

2018
Peng Hu Jia Shang Wenhong Zhang Guozhong Gong Yongguo Li Xinyue Chen Jianning Jiang Qing Xie Xiaoguang Dou Yongtao Sun Yufang Li Yingxia Liu Guozhen Liu Dewen Mao Xiaoling Chi Hong Tang Xiaoou Li Yao Xie Xiaoping Chen Jiaji Jiang Ping Zhao Jinlin Hou Zhiliang Gao Huimin Fan Jiguang Ding Dazhi Zhang Hong Ren

Background and Aims: Hepatitis B surface antigen (HBsAg) loss is seldom achieved with nucleos(t)ide analog (NA) therapy in chronic hepatitis B patients but may be enhanced by switching to finite pegylated-interferon (Peg-IFN) alfa-2a. We assessed HBsAg loss with 48- and 96-week Peg-IFN alfa-2a in chronic hepatitis B patients with partial response to a previous NA. Methods: Hepatitis B e antigen...

Journal: :Journal of immunology 2003
Sue-Jane Lin Pei-Yun Shu Chungming Chang Ah-Kau Ng Cheng-po Hu

IL-4 has been known as a Th2 cytokine and can act on B cells, T cells, and monocytes. In this study we demonstrate that IL-4Rs are expressed on human hepatocellular carcinoma (HCC) cells. We found that IL-4 suppresses hepatitis B surface Ag (HBsAg) mRNA and HBsAg production in the Hep3B cell line, which contains an integrated hepatitis B virus (HBV) genome and constitutively secretes HBsAg. Whe...

2006
V V Ionasescu

Sir, I read with interest the paper by Mollica et al.1 and should like to add the results of our prospective study for comparison with other Mediterranean countries on 37 HBsAg mothers who were found among 1002 pregnant women attending a maternity hospital. Although 3.7% of the mothers were positive for HBsAg, only in 0. 1 % of cord blood specimens was HBsAg demonstrable by counter electrophore...

2010
H Scheiblauer M El-Nageh S Diaz S Nick H Zeichhardt H-P Grunert A Prince

BACKGROUND AND OBJECTIVES This study was conducted by the International Consortium for Blood Safety (ICBS) to identify high-quality test kits for detection of hepatitis B virus (HBV) surface antigen (HBsAg) for the benefit of developing countries. MATERIALS AND METHODS The 70 HBsAg test kits from around the world were evaluated comparatively for their clinical sensitivity, analytical sensitiv...

2011
Ming-Lun Yeh Chao-Hung Hung Jee-Fu Huang Chun-Jen Liu Chuan-Mo Lee Chia-Yen Dai Jing-Houng Wang Zu-Yau Lin Sheng-Nan Lu Tsung-Hui Hu Ming-Lung Yu Jia-Horng Kao Wan-Long Chuang Pei-Jer Chen Ding-Shinn Chen

BACKGROUND Interferon-α/ribavirin combination therapy might promote hepatitis B surface antigen (HBsAg) seroclearance in patients dually infected with hepatitis B and C viruses (HBV/HCV), but the long-term effect remains unclear. We aimed to investigate the rate of and the factors associated with HBsAg seroclearance during long-term follow-up after interferon-α/ribavirin combination therapy in ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید